Abstract
Bromocriptine mesylate, a long-acting dopamine agonist, is a semisynthetic ergot-derived alkaloid that has been used clinically since 1969.<sup>1</sup>This drug has been effective in the management of patients with hyperprolactinemia with or without a demonstrable prolactin-secreting adenoma, growth hormone-secreting pituitary adenomas, postpartum lactation, and Parkinson's disease.<sup>2</sup>The drug also has been safely used in the management of pregnant women harboring prolactin-secreting pituitary tumors.<sup>3</sup>In addition, the drug has been tried in some patients with luteal-phase insufficiency, idiopathic edema, premenstrual tension syndrome, and hepatic encephalopathy, although the data supporting the use of the drug in these latter conditions either are incomplete or require substantiation.<sup>1</sup> During the 20 years of clinical experience, bromocriptine has been found to be remarkably free of major side effects.<sup>4</sup>Patients commonly develop nausea, occasionally with abdominal cramps and vomiting, and postural hypotension at the time therapy is initiated. These side effects can
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
